Rhophylac 300 MCG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXNB3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,111
Award facts
- Contract value 100% obligated
- $1,110.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,110.72 to AmerisourceBergen Drug Corp for Rhophylac 300 mcg/2 mL syringes on November 24, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rhophylac is a Rh(D) immune globulin used to prevent Rh immunization in at-risk patients, representing a critical pharmaceutical product for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The contractor's receipt of multiple competitively awarded delivery orders demonstrates its capability to fulfill federal procurement requirements for time-sensitive medical commodities needed by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXNB3?
SPE2DR26FXNB3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FXNB3 worth?
The government has obligated $1,111 on SPE2DR26FXNB3.
Is contract SPE2DR26FXNB3 an order under another contract?
Yes. SPE2DR26FXNB3 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNB3 competed?
The extent of competition for SPE2DR26FXNB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award